Additionally, pro-inflammatory signaling (F2RL3 and IL2RA) may interact with transcriptional regulators (SOBP and SIX3) to drive leukemic cell proliferation or hinder normal differentiation, further contributing to AML progression. Here, SOBP is linked to acute myeloid leukemia.